The Process

Two engines.
One platform.

Vainture Signal scores commercialization viability across six dimensions. Vainture Patent vets patentability across seven prior art sources. Each engine is independent and producible standalone — and a fileable patent verdict continues into the Filing Platform, which routes the invention to the right instrument and prepares the application for a practitioner to review, sign, and file.

The Vainture Signal Process

Commercialization analysis at the speed of decision.

Every idea runs through the same six-dimension evaluation and earns a Signal Score backed by named markets, named competitors, named investors, and named funding sources.

01

Intake

Scientists submit ideas through a structured form, or paste existing IP — a patent abstract, an invention disclosure, a patent number. Two paths in. Same evaluation pipeline.

2 minutes
02

Evaluate

The AI runs a multi-dimensional commercialization analysis with live web search. Real market data. Real competitors. Real investors. Real funding sources. Six dimensions, all scored.

30 to 90 seconds
03

Form

Every evaluation produces a Vainture Signal Report — executive summary, market opportunity, competitive landscape, regulatory pathway, named investors, named partners, named funding programs, ranked next steps. Proceed, pivot, or decline — each verdict comes with the evidence behind it.

Auto-generated
04

Launch

The portfolio dashboard surfaces the highest-scoring opportunities for institutional decision-making. Investors review pre-evaluated pipelines as part of due diligence. Resources flow to ideas with evidence behind them.

Ongoing

Signal: how we evaluate

Six dimensions. One overall score.

Every Signal evaluation is scored across the six dimensions that determine whether an innovation can become a venture. Weights are fixed and transparent.

Market Opportunity

25%

Total addressable market, serviceable market, growth rate, key drivers and barriers. Real numbers from current sources, not training data.

Competitive Landscape

20%

Named competitors with their approach, differentiation analysis, competitive risk assessment. We name companies, not categories.

Regulatory Pathway

15%

Likely FDA pathway, estimated timeline and cost, expedited options (Breakthrough, Fast Track, Orphan), key regulatory risks.

Investor Landscape

15%

Named VC firms, family offices, and strategic investors that have funded comparable companies. Recent deals, typical check sizes, stages.

Strategic Partners

15%

Named pharma, biotech, medtech, and device companies that would be logical licensing partners or acquirers. Recent deal activity.

Public Funding

10%

Named NIH FOAs, CPRIT programs, DARPA, BARDA, NSF, foundation grants, SBIR/STTR. Award amounts and deadlines where available.

The Vainture Patent Process

Patentability vetting before the practitioner is engaged.

The IP gate is the most expensive question in the TTO queue — the §102(b) one-year bar makes it time-bounded. Vainture Patent answers it in five minutes with citation-grade rigor.

01

Intake

Disclosure intake — abstract, technical description, claims-of-interest if available. Same form as Signal; the engine decides what to consume.

Under 2 minutes
02

Retrieve

Multi-source prior art retrieval across USPTO, EPO Espacenet, PubMed, Semantic Scholar, arXiv, Lens.org, and Google Patents (standby).

Parallel adapters
03

Score

Citation-gated relevance scoring. Every prior-art hit comes with the specific passage that supports it. §102 anticipation and §103 obviousness risk mapped per claim.

Deterministic
04

Verdict

0–100 defensibility score with a verdict — File as-is, File with narrowed claims, or Do not file — plus draft claims at broad / medium / narrow scope and a 150-word USPTO abstract.

Auto-generated
05

Handoff

TTO and Practitioner DOCX variants with the locked 37 CFR §1.56 candor footer. Routed to a registered patent practitioner of record — we never file.

Practitioner-ready

Why this is different

We are not an incubator. We are not a tech transfer office.

vs. Traditional Incubators

Incubators are biased toward saying yes — their cohort fills regardless of idea quality. Vainture Signal scores every idea against the same evidence threshold so the institution funds the ones that clear it.

vs. Tech Transfer Offices

TTOs are over-stretched and under-resourced. A small team manually reviews every disclosure. Vainture lets that team focus on the few ideas that actually have commercial potential — and lets IP counsel vet patentability without firing up Google for every disclosure.

vs. Manual Consulting / Drafting

A senior commercialization analyst takes weeks to produce one report. A patent practitioner spends days on the prior art search alone. Vainture produces structured output in minutes for both — and runs across the entire portfolio.

After the patent verdict — Route & Prepare

The patent track continues into a practitioner-ready filing.

A fileable verdict does not stop at claims and an abstract. The Filing Platform routes the invention to the right instrument, drafts the application grounded only in the disclosure, and moves it through practitioner review to sign-off. Vainture never files and never gives legal advice.

  1. 1

    Claims & Abstract Drafted

    The patent engine produces draft claims and a 150-word abstract — the accurate output at this point, not a full application.

  2. 2

    Filing Strategy

    The router recommends an instrument across eight pathways, cited to statute and MPEP, with §101 flags and honest confidence.

  3. 3

    Application Preparation

    A guided interview drives section-by-section drafting, checked by a live accuracy panel of 20+ automated checks.

  4. 4

    Attorney Review

    Section-by-section approve / comment / flag, with HIGH-severity flags blocking sign-off until resolved.

  5. 5

    Approved for Filing

    Page-numbered USPTO-order DOCX/PDF exports with SB/16 cover data and an auto-generated IDS — ready for the practitioner to sign and file.

Run both engines

One disclosure, both verdicts, side by side.

Submit one disclosure and run Signal and Patent in parallel. Both verdicts render side by side and your reviewer records the combined read — for the rooms where commercialization and patentability decisions are made together.

See both engines in action.

We are running live demonstrations for research institutions and venture firms. Tell us about your pipeline, and we will walk you through the platform.